Picture of Vanta Bioscience logo

540729 Vanta Bioscience Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m-10.92%
3m+33.99%
6m+49.39%
1yr-17.44%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-30.29%
50d MA+12.62%
200d MA+6.03%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-4.06%
Return on Equity-23.2%
Operating Margin-27.9%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueIN₹m124.25141.43100.3896.8862.76n/an/a9.5%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+2983.96+3.21-56.88-79.6n/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Vanta Bioscience EPS forecast chart

Profile Summary

Vanta Bioscience Limited is an India-based preclinical contract research company. The Company is providing services of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research and environmental studies. It offers a host of preclinical safety assessment services for clientele from pharmaceutical, medical devices, nutraceuticals, feed additive, biotech, agrochemicals, cosmetics, and chemical industries. In addition, it also provides risk assessment services for evaluating the safety of the active pharmaceutical ingredients (API), excipients, extractable and leachable, including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. It also provides services for determination of health-based exposure limits, such as permitted daily exposure (PDE) or allowable daily exposure (ADE), including occupational exposure limits (OEL) for pharmaceutical manufacturers.

Directors

Last Annual
March 31st, 2023
Last Interim
September 30th, 2023
Incorporated
April 29th, 2016
Public Since
October 6th, 2017
No. of Employees
56
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
in flag iconBombay Stock Exchange
Shares in Issue
6,312,000

540729 Share Price Performance

Upcoming Events for 540729

Similar to 540729

Picture of Chemo Pharma Laboratories logo

Chemo Pharma Laboratories

in flag iconBombay Stock Exchange

Picture of Indo US Bio-Tech logo

Indo US Bio-Tech

in flag iconBombay Stock Exchange

Picture of Jeevan Scientific Technology logo

Jeevan Scientific Technology

in flag iconBombay Stock Exchange

Picture of Shree Ganesh Remedies logo

Shree Ganesh Remedies

in flag iconBombay Stock Exchange

Picture of Transgene Biotek logo

Transgene Biotek

in flag iconBombay Stock Exchange

FAQ